Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

FDA launches new tool aimed at easier access to adverse event data

Published 09/28/2017, 04:19 PM
Updated 09/28/2017, 04:19 PM
© Reuters.  FDA launches new tool aimed at easier access to adverse event data
  • The FDA introduces a new search tool that it says will be make it much easier for consumers, providers and researchers to access adverse event data through the FDA's Adverse Event Reporting System ((FAERS)).
  • The new dashboard enables users to search for and organize data by such criteria as drug/biologic product, patient age, type of adverse event and the year the event occurred or within a particular timeframe.
  • The agency hopes the increased transparency will increase the submission of more detailed and complete reports from consumers, healthcare professionals and others by making it easier for them to see other reports the FDA receives.
  • IBB XBI FBT BBH BIB PBE PJP IHE XPH PPH GNRX GILD BIIB AMGN MRK LLY BMY MRK CELG PFE OTCQX:RHHBY NVS
  • Now read: Celgene Presents Strong Potential Despite Clinical Hold Setback


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.